Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Longsworth Todd Christopher
General Counsel at NovoCure. Filing since 29 Jan 2018.
CIK 0001693530
Company
Date
Role
Action
Shares
Amount
Of holding
NVCR
NovoCure Ltd
8 Mar 2022
General Counsel
Sold, plan not stated
2,339
$163.96K
3.6%
NVCR
NovoCure Ltd
4 Mar 2022
General Counsel
Sold, plan not stated
1,973
$138.91K
3.0%
NVCR
NovoCure Ltd
3 Mar 2022
General Counsel
Sold, plan not stated
1,094
$81.50K
1.6%
NVCR
NovoCure Ltd
8 Mar 2021
General Counsel
Sold, plan not stated
2,404
$314.46K
3.4%
NVCR
NovoCure Ltd
4 Mar 2021
General Counsel
Sold, plan not stated
3,084
$424.22K
4.2%
NVCR
NovoCure Ltd
2 Mar 2021
General Counsel
Sold, plan not stated
2,355
$358.08K
3.6%
NVCR
NovoCure Ltd
15 Jan 2021
General Counsel
Sold, plan not stated
63,814
$11.01M
51.7%
NVCR
NovoCure Ltd
6 Mar 2020
General Counsel
Sold, plan not stated
2,499
$173.77K
2.8%
NVCR
NovoCure Ltd
28 Feb 2020
General Counsel
Sold, plan not stated
2,643
$190.86K
3.6%
NVCR
NovoCure Ltd
25 Feb 2020
General Counsel
Sold, plan not stated
8,482
$688.37K
11.2%
NVCR
NovoCure Ltd
3 Sep 2019
General Counsel
Sold, plan not stated
158,440
$13.92M
74.6%
NVCR
NovoCure Ltd
28 Feb 2019
General Counsel
Sold, plan not stated
2,368
$127.11K
6.0%
NVCR
NovoCure Ltd
25 Feb 2019
General Counsel
Sold, plan not stated
9,325
$500.08K
21.7%
NVCR
NovoCure Ltd
25 Jan 2019
General Counsel
Sold, plan not stated
11,874
$595.48K
35.8%
NVCR
NovoCure Ltd
24 Jan 2019
General Counsel
Sold, plan not stated
15,000
$722.25K
41.3%
NVCR
NovoCure Ltd
16 Jan 2019
General Counsel
Sold, plan not stated
15,000
$677.25K
41.3%
NVCR
NovoCure Ltd
9 Jan 2019
General Counsel
Sold, plan not stated
15,000
$602.25K
41.3%
NVCR
NovoCure Ltd
23 Feb 2018
General Counsel
Sold, plan not stated
6,591
$130.69K
24.7%
NVCR
NovoCure Ltd
29 Jan 2018
General Counsel
Sold, plan not stated
11,630
$279.12K
69.9%
19 decisions on file.
